We are live on ! Find out more
VYGR icon

Voyager Therapeutics

121 hedge funds and large institutions have $277M invested in Voyager Therapeutics in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 49 increasing their positions, 37 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,056% more call options, than puts

Call options by funds: $194K | Put options by funds: $9K

32% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 37

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

1.73% less ownership

Funds ownership: 83.23%81.5% (-1.7%)

12% less funds holding

Funds holding: 138121 (-17)

36% less capital invested

Capital invested by funds: $430M → $277M (-$153M)

64% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 25

Holders
121
Holders Change
-17
Holders Change %
-12.32%
% of All Funds
2.67%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
9
Increased
49
Reduced
37
Closed
25
Calls
$194K
Puts
$9K
Net Calls
+$185K
Net Calls Change
-$632K
Name Holding Trade Value Shares
Change
Change in
Stake
Marshall Wace
26
Marshall Wace
United Kingdom
$1.78M +$2.23M +194,444 New
Bank of Montreal
27
Bank of Montreal
Ontario, Canada
$1.43M -$59.3K -5,163 -3%
FT
28
Fiduciary Trust
Massachusetts
$1.42M
B
29
Bailard
California
$1.29M -$310K -27,000 -16%
Man Group
30
Man Group
United Kingdom
$1.25M +$218K +18,975 +16%
Citadel Advisors
31
Citadel Advisors
Florida
$1.06M -$4.39M -382,157 -77%
HAM
32
HHR Asset Management
New Jersey
$946K
Ameriprise
33
Ameriprise
Minnesota
$873K +$5.97K +520 +0.5%
NIM
34
Needham Investment Management
New York
$824K +$803K +70,000 +350%
AG
35
Algert Global
California
$809K +$7K +610 +0.7%
American Century Companies
36
American Century Companies
Missouri
$808K +$6.41K +558 +0.6%
Los Angeles Capital Management
37
Los Angeles Capital Management
California
$796K +$430K +37,497 +76%
Invesco
38
Invesco
Georgia
$770K +$51.7K +4,503 +6%
HW
39
Hancock Whitney
Mississippi
$686K +$860K +74,953 New
Russell Investments Group
40
Russell Investments Group
United Kingdom
$667K -$21.1K -1,841 -2%
Two Sigma Advisers
41
Two Sigma Advisers
New York
$657K -$235K -20,500 -22%
QI
42
QS Investors
New York
$653K +$3.44K +300 +0.4%
AA
43
ALPS Advisors
Colorado
$617K -$90.2K -7,863 -10%
TI
44
Trexquant Investment
Connecticut
$615K +$526K +45,818 +215%
BNP Paribas Asset Management
45
BNP Paribas Asset Management
France
$540K +$38K +3,313 +6%
Capital Fund Management (CFM)
46
Capital Fund Management (CFM)
France
$539K -$201K -17,553 -23%
AQR Capital Management
47
AQR Capital Management
Connecticut
$536K -$137K -11,926 -17%
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$489K +$109K +9,480 +22%
Swiss National Bank
49
Swiss National Bank
Switzerland
$485K
AGA
50
Altrinsic Global Advisors
Connecticut
$458K +$574K +50,000 New

VYGR Hedge Fund Activity: Q1 2020 in Review

121 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q1 2020, worth a combined $277M — down 36% from $430M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of VYGR and 9 opened new positions — a net loss of 16 holders — while 37 trimmed existing stakes and 49 added.

The largest buyer was Armistice Capital, adding an estimated $7.02M. The largest seller was Federated Hermes, cutting an estimated $6.29M.

  • 121 institutional investors held Voyager Therapeutics (VYGR) as of Q1 2020, down from 138 in Q4 2019.
  • Funds reported $277M of Voyager Therapeutics stock for Q1 2020, down 36% quarter-over-quarter.
  • 9 funds opened new Voyager Therapeutics positions in Q1 2020 and 25 closed out, a net change of -16 holders.
  • The largest Voyager Therapeutics buyer in Q1 2020 was Armistice Capital, an estimated $7.02M added.
  • The largest Voyager Therapeutics seller in Q1 2020 was Federated Hermes, an estimated $6.29M sold.

Based on aggregated 13F filings for Q1 2020.